Corticotropin therapy in myasthenia gravis: indications and limitations.
D000324:Adrenocorticotropic Hormone / Q000009:adverse effects / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000601:surgery; D013934:Thymectomy
D002800:Cholinesterase Inhibitors; D000324:Adrenocorticotropic Hormone